New psoriasis drug shows promise in early trial
Disease control
Not yet recruiting
This study tests an experimental drug called D-2570 in 75 adults with moderate to severe plaque psoriasis. Participants will receive either the drug or a placebo to see if it safely improves skin symptoms. The main goal is to measure at least a 90% reduction in psoriasis severity…
Phase: PHASE2 • Sponsor: InventisBio Co., Ltd • Aim: Disease control
Last updated May 17, 2026 05:50 UTC